trending Market Intelligence /marketintelligence/en/news-insights/trending/U1DUYeRpS8Y1qOpucgRalQ2 content esgSubNav
In This List

Gresham House Ventures backs Cisiv


S&P Capital IQ Pro | Powering Your Edge


Street Talk Episode 81: Amid strong recovery, Banc of California hearing more M&A chatter


S&P Capital IQ Pro | Unrivaled Sector Coverage


Banking Essentials Newsletter: September Edition

Gresham House Ventures backs Cisiv

Gresham House Ventures invested in technology company Cisiv Ltd. using funds from Baronsmead Venture Capital Trusts.

Cisiv provides electronic data capture, management and analytics to pharmaceutical companies and clinical research organizations.

The investment, made alongside current sponsor Albion Capital Group LLP, will aid the company as it develops its technology and expands its presence in the U.S., including setting up a sales team in the country.

Gresham House Ventures supports businesses with equity of up to £5 million. It is part of the strategic equity division of asset investment manager Gresham House PLC.